Filtered By:
Condition: Atrial Fibrillation
Countries: USA Health
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 257 results found since Jan 2013.
Atrial Fibrillation: An Update for Home Healthcare Clinicians
This article reviews the guideline for the management of patients with atrial fibrillation by the American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines and provides recommendations for home healthcare clinicians.
Source: Home Healthcare Nurse - January 1, 2021 Category: Nursing Tags: Feature: NCPD Connection Source Type: research
Women and atrial fibrillation
AbstractAtrial fibrillation (AF) remains a growing problem in the United States and worldwide, imposing a high individual and health system burden, including increased resource consumption due to repeated hospitalizations, stroke, dementia, heart failure, and death. This comprehensive review summarizes the most recent data on sex ‐related differences in risks associated with AF. Women with AF have increased risk of stroke and death compared to men, and possible reasons for this disparity are explored. Women also continue to have worse symptoms and quality of life, and poorer outcomes with stroke prevention, as well as wi...
Source: Journal of Cardiovascular Electrophysiology - December 29, 2020 Category: Cardiology Authors: Annabelle Santos Volgman,
Emelia J. Benjamin,
Anne B. Curtis,
Margaret C. Fang,
Kathryn J. Lindley,
Gerald V. Naccarelli,
Carl J. Pepine,
Odayme Quesada,
Marmar Vaseghi,
Albert L. Waldo,
Nanette K. Wenger,
Andrea M. Russo,
American College of Tags: REVIEW Source Type: research
Women and Atrial Fibrillation
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - December 17, 2020 Category: Cardiology Authors: Annabelle Santos Volgman,
Emelia J. Benjamin,
Anne B. Curtis,
Margaret C. Fang,
Kathryn J. Lindley,
Gerald V. Naccarelli,
Carl J. Pepine,
Odayme Quesada,
Marmar Vaseghi,
Albert L. Waldo,
Nanette K. Wenger,
Andrea M. Russo,
for the American Col Tags: REVIEW Source Type: research
Benefit-Risk Tradeoffs in Assessment of New Drugs and Devices.
Abstract
Balancing benefits and risks is a complex task that poses a major challenge, both to the approval of new medicines and devices by regulatory authorities and in therapeutic decision-making in practice. Several analysis methods and visualization tools have been developed to help evaluate and communicate whether the benefit-risk profile is favorable or unfavorable. In this White Paper, we describe approaches to benefit-risk assessment using qualitative approaches such as the Benefit Risk Action Team framework developed by the Pharmaceutical Research and Manufacturers of America, and the Benefit-Risk Framewor...
Source: Circulation - November 17, 2020 Category: Cardiology Authors: Kaul S, Stockbridge N, Butler J Tags: Circulation Source Type: research
Contemporary procedural trends of Watchman percutaneous left atrial appendage occlusion in the United States
ConclusionIn contemporary United States clinical practice, Watchman utilization has increased significantly since approval in 2015, while complications and in ‐patient mortality have declined.
Source: Journal of Cardiovascular Electrophysiology - November 11, 2020 Category: Cardiology Authors: Muhammad Bilal Munir,
Muhammad Zia Khan,
Douglas Darden,
Deepak K. Pasupula,
Sudarshan Balla,
Frederick T. Han,
Ryan Reeves,
Jonathan C. Hsu Tags: ORIGINAL ARTICLES Source Type: research
Contemporary Procedural Trends of Watchman Percutaneous Left Atrial Appendage Occlusion in the United States
ConclusionIn contemporary United States clinical practice, Watchman utilization has increased significantly since approval in 2015, while complications and in ‐patient mortality have declined.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - November 5, 2020 Category: Cardiology Authors: Muhammad Bilal Munir,
Muhammad Zia Khan,
Douglas Darden,
Deepak Kumar Pasupula,
Sudarshan Balla,
Frederick T. Han,
Ryan Reeves,
Jonathan C. Hsu Tags: ORIGINAL ARTICLES Source Type: research
Remaining Challenges With Transcatheter Left Atrial Appendage Closure
Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However, certain issues remain unresolved with the technology. Knowledge of these issues, their significance, and the current and future efforts to resolve them is key for proper informed decision making by physicians and patients.
Source: Mayo Clinic Proceedings - September 30, 2020 Category: Internal Medicine Authors: Mohamad Alkhouli, David R. Holmes Tags: Concise review for clinicians Source Type: research
Managing Ischemic Stroke in Patients Already on Anticoagulation for Atrial Fibrillation: A Nationwide Practice Survey
We sought to understand practice patterns in management of patients who have ischemic stroke while adherent to oral anticoagulation for non-valvular atrial fibrillation (NVAF) in the United States (US).
Source: Journal of Stroke and Cerebrovascular Diseases - September 11, 2020 Category: Neurology Authors: Setareh Salehi Omran, Neal S. Parikh, Maria Zambrano Espinoza, Mackenzie P. Lerario, Steven R. Levine, Hooman Kamel, Randolph Marshall, Joshua Willey Source Type: research
Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis.
CONCLUSION: In subjects with liver cirrhosis, AF is associated with higher rates of inpatient mortality, stroke, and acute kidney injury compared to those who do not have the cardiac arrhythmia.
PMID: 32843936 [PubMed]
Source: World Journal of Cardiology - July 25, 2020 Category: Cardiology Authors: Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M Tags: World J Cardiol Source Type: research
Meta-analysis of the efficacy and safety of non-vitamin K antagonist oral anticoagulants with warfarin in Latin American patients with atrial fibrillation
Conclusions:
Our meta-analysis suggested that the use of NOACs was at least non-inferior to warfarin use for stroke prevention in Latin American patients with AF.
Source: Medicine - May 1, 2020 Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
Trends in the Utilization of Left Atrial Appendage Exclusion in the United States
Stroke prevention remains a cornerstone in the management of patients with non-valvular atrial fibrillation (NVAF)1. Oral anticoagulation (OAC) is the main method of stroke prevention in NVAF worldwide. However,>50% of high-risk NVAF patients are not maintained on OAC due to comorbidities, frailty, bleeding complications, or non-compliance2. In 1996, Blackshear proposed Left atrial appendage exclusion (LAAE) as an alternative stroke prevention strategy in NVAF3. Because no randomized data were available to support the routine use of LAAE, its utilization remained initially limited to selected patients undergoing a concomitant cardiac surgery.
Source: The American Journal of Cardiology - April 6, 2020 Category: Cardiology Authors: Safi U. Khan, Muhammad Zia Khan, Mohamad Alkhouli Source Type: research
Reader's Comments: Trends in the Utilization of Left Atrial Appendage Exclusion in the United States
Stroke prevention remains a cornerstone in the management of patients with nonvalvular atrial fibrillation (NVAF).1 Oral anticoagulation is the main method of stroke prevention in NVAF worldwide. However,>50% of high-risk NVAF patients are not maintained on oral anticoagulation due to comorbidities, frailty, bleeding complications, or noncompliance.2 In 1996, Blackshear proposed left atrial appendage exclusion (LAAE) as an alternative stroke prevention strategy in NVAF.3 Because no randomized data were available to support the routine use of LAAE, its utilization remained initially limited to selected patients undergoing a...
Source: The American Journal of Cardiology - April 6, 2020 Category: Cardiology Authors: Safi U. Khan, Muhammad Zia Khan, Mohamad Alkhouli Source Type: research
Johnson & Johnson Launches Heartline ™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
New Brunswick, NJ, February 25, 2020 — Johnson & Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline™ Study, individuals must be age 65 or older...
Source: Johnson and Johnson - February 25, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Mobile-ECG screening in rural pharmacies: Rates of atrial fibrillation and associated risk factors
Atrial fibrillation (AFib) marks a significant health care burden with more than 46.3 million patients worldwide, and more than 6.1 million United States (US) adults experiencing at least one episode of AFib.3 The risk of stroke is significantly elevated in AFib patients and may not provide symptomatic cues of its occurrence.1 The importance and impact of AFib prompt the need for efficient identification and treatment of AFib across community settings.
Source: Heart and Lung - January 31, 2020 Category: Intensive Care Authors: Caley M. Kropp, Nichelle L. Huber, David Sager, Connor Tripp, Ashley Burch, Aditi Naniwadekar, Rajasekhar Nekkanti, Murrium I. Sadaf, J. Paul Mounsey, Samuel F. Sears Source Type: research
Global research productions pertaining to atrial fibrillation from 2004 to 2018: A bibliometric analysis
Conclusion:
Bibliometric analysis of the literature shows that research on AF continues to be a hot spot, and the clinical treatment of AF is an important research frontier. However, further research and collaboration are needed worldwide. Our findings aim to provide valuable information for the editors of journals that publish research on arrhythmia, and to help researchers identify new perspectives for future researches.
Source: Medicine - January 1, 2020 Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
